uniQure N.V.
QURE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590560
In the last 90 days, uniQure N.V. insiders filed 0 open-market purchases and 1 sale; 257 institutions reported holding it in 13F filings for Q2 2026, worth $3.02B in total; Maverick Capital is the only superinvestor holding it.
Key figures
- Market capClose on Nov 16, 2026
- $1.53B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $192.9K in total
- 1
- 13F holdersQ2 2026, +41 vs. previous quarter
- 257
- 13F valueReported value at the end of Q2 2026
- $3.02B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $16.1M
- −40.6% year over year
- Net income, FY2025
- -$199.0M
- No comparable prior period
- Free cash flow, FY2025
- -$178.4M
- No comparable prior period
- Revenue, Q3 FY2026
- $5.20M
- +40.4% year over year
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 8.51M
- Shares sold short
- Change
- −219.1K
- −2.5% vs. previous
- Days to cover
- 6.39
- At average daily volume
Superinvestors holding QURE, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding uniQure N.V. on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
See all insider tradesOpen-market purchases and sales by uniQure N.V. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2026 (view filing)4:04 PM ET | Nov 6 | 4 days | Meek David D.Director | SSale | −9.08K | $21.25 | −$192.9K | −22.8%30.7K after | 10b5-1 |
| Jul 7, 2026 (view filing)4:47 PM ET | Jul 2 | 5 days | Kapusta Matthew CCEO, Managing Director | SSale | −21.1K | $45.16 | −$952.1K | −3.9%519.2K after | 3 lots10b5-1 |
| Jul 2, 2026 (view filing)4:59 PM ET | Jun 30 | 2 days | Abi-Saab WalidChief Medical Officer | SSale | −30.0K | $46.42 | −$1.39M | −16.8%148.2K after | 2 lots10b5-1 |
| Jul 2, 2026 (view filing)4:54 PM ET | Jun 30 | 2 days | Kaye JackDirector | SSale | −21.2K | $46.44 | −$983.0K | −44.9%26.0K after | 2 lots10b5-1 |
| Jun 30, 2026 (view filing) | Jun 26 | 4 days | Abi-Saab WalidChief Medical Officer | SSale | −1.43K | $46.86 | −$67.2K | −0.8%168.2K after | |
| Jun 26, 2026 (view filing) | Jun 24-25 | 2 days | Kapusta Matthew CCEO, Managing Director | SSale | −35.4K | $50.02 | −$1.77M | −6.4%519.2K after | 2 lots10b5-1 |
| Jun 22, 2026 (view filing) | Jun 17-18 | 5 days | Kapusta Matthew CCEO, Managing Director | SSale | −206.1K | $45.47 | −$9.37M | −28.3%521.8K after | 8 lots10b5-1 |
| Jun 22, 2026 (view filing) | Jun 17 | 5 days | Balachandran MadhavanDirector | SSale | −11.7K | $45.06 | −$526.5K | −21.3%43.3K after | 3 lots10b5-1 |
| Jun 22, 2026 (view filing) | Jun 17 | 5 days | Kaye JackDirector | SSale | −5.29K | $42.57 | −$225.4K | −16.9%26.0K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Balachandran MadhavanDirector | SSale | −10.0K | $27.85 | −$278.5K | −18.8%43.3K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 257 holdersThe largest institutional positions in uniQure N.V. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 6,727,777 | $309.9M | 2.78% | +768,182+12.9% | Added |
| JPMorgan Chase & Co | 4,867,755 | $230.8M | 0.01% | +2,030,289+71.6% | Added |
| RTW Investments, LP | 3,941,572 | $181.5M | 1.55% | +1,355,216+52.4% | Added |
| State Street Corp | 2,903,825 | $133.8M | 0.00% | +643,313+28.5% | Added |
| Standard Life Aberdeen plc | 2,848,117 | $131.2M | 0.18% | −2,458,269−46.3% | Reduced |
| BlackRock, Inc. | 1,877,453 | $86.5M | 0.00% | +143,995+8.3% | Added |
| OrbiMed Advisors LLC | 1,807,486 | $83.3M | 1.58% | −328,663−15.4% | Reduced |
| Jane Street Group, LLC | 1,610,483 | $74.2M | 0.05% | +974,488+153.2% | Added |
| Jennison Associates LLC | 1,561,412 | $71.9M | 0.04% | +327,623+26.6% | Added |
| Boxer Capital Management, LLC | 1,503,300 | $69.2M | 5.21% | +841,300+127.1% | Added |
Holders of 5% or more of QURE
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of uniQure N.V..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 13G/A | 9.87%6.15M shares | +3.27 ppfrom 6.60% | Aug 14, 20252 filings | Feb 17, 2026 | SEC |
| JPMorgan Chase & Co | 13G/A | 8.50%5.95M shares | +1.50 ppfrom 7.00% | Jul 16, 20262 filings | Oct 16, 2026 | SEC |
| RTW Investments, LP | 13G | 5.70%3.94M shares | +1.60 ppfrom 4.10% | May 15, 20256 filings | Aug 14, 2026 | SEC |